Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Urothelial Cancer

Clinical Trial at: Texas Oncology - New Braunfels

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer (SGN22E-002)

  • Details

ClinicalTrials.gov ID: NCT03288545
Diagnosis Type: NA
USOR Number: 20172

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - New Braunfels

BYLieve: A phase II, multicenter, open-label, three-cohort, noncomparative study to assess the efficacy and safety of alpelisib plus fulvestrant or letrozole in patients with PIK3CA mutant,hormone receptor (HR) positive, HER2-negative advanced breast cancer (aBC), who have progressed on or after prior treatments (CBYL719X2402)

  • Details

ClinicalTrials.gov ID: NCT03056755
Diagnosis Type: NA
USOR Number: 17026

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - New Braunfels

A Phase 1b-2 Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer (PCR2002 Quest) (64091742PCR2002)

  • Details

ClinicalTrials.gov ID: NCT03431350
Diagnosis Type: NA
USOR Number: 19146

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - New Braunfels

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: Non-Hodgkins
USOR Number: 18155

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Leukemia

Clinical Trial at: Texas Oncology - New Braunfels

A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)

  • Details

ClinicalTrials.gov ID: NCT03734016
Diagnosis Type: CLL
USOR Number: 18155

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - New Braunfels

CYCLONE 2: A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Myelomas

Clinical Trial at: Texas Oncology - New Braunfels

(Amgen 20180015) A Randomized, Open-label, Phase 3 Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination with Lenalidomide and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma (A.R.R.O.W.2).

  • Details

ClinicalTrials.gov ID: NCT03859427
Diagnosis Type: NA
USOR Number: 19036

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - New Braunfels

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer(64091742PCR3001)

  • Details

ClinicalTrials.gov ID: NCT03748641
Diagnosis Type: NA
USOR Number: 18103

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Texas Oncology - New Braunfels

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - New Braunfels

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Non-Hodgkins
USOR Number: 11282

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - New Braunfels

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: NA
USOR Number: 19208

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Essential Thrombocythemia

Clinical Trial at: Texas Oncology - New Braunfels

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Texas Oncology - New Braunfels

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)

  • Details

ClinicalTrials.gov ID: NCT03165734
Diagnosis Type: NA
USOR Number: 19171

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - New Braunfels

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number: 19092

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - New Braunfels

QBGJ398-302: Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF302)

  • Details

ClinicalTrials.gov ID: NCT04197986
Diagnosis Type: NA
USOR Number: 19094

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - New Braunfels

Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer (64091742PCR0002)

  • Details

ClinicalTrials.gov ID: NCT03871816
Diagnosis Type: NA
USOR Number: 19144

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - New Braunfels

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG®)Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - New Braunfels

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: NA
USOR Number: 19054

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - New Braunfels

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - New Braunfels

Single Arm, Open Label Phase 1b/2 Study of SGN-LIV1A in Combination with Pembrolizumab for First-Line Treatment of Patients with Unresectable Locally-Advanced or Metastatic Triple-Negative Breast Cancer (SGNLVA-002)

  • Details

ClinicalTrials.gov ID: NCT03310957
Diagnosis Type: NA
USOR Number: 18004

  • Practice Details

1448 East Common St
New Braunfels, Texas 78130
526.93 mi. away
P: (830) 643-1762

More Details View Practice Page

Pages